Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (21-30 of 352) with videos related to

Pageof 36
Sort By:
Journal of Crohn'S & Colitis|August 24, 2022
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical ResearchNeeraj Narula, Shahin Merat, David Liu, et al.
Journal of Crohn'S & Colitis|June 11, 2020
Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 PandemicWalter Reinisch, Silvio Danese, Laurent Peyrin-Biroulet, et al.
British Journal of Clinical Pharmacology|November 13, 2020
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease managementAna-Marija Grisic, Alexander Eser, Wilhelm Huisinga, et al.
Gut|March 23, 2021
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare SystemNabeel Khan, Nadim Mahmud, Chinmay Trivedi, et al.
Journal of Crohn'S & Colitis|July 26, 2023
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial DataRyan C Ungaro, Harisha Kadali, Wenwen Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
Clinical Decision Support Tool for Infliximab in Crohn's DiseaseParambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
Human Mutation|August 19, 2006
Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme functionElke Schaeffeler, Michel Eichelbaum, Walter Reinisch, et al.
Inflammatory Bowel Diseases|August 20, 2020
Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI TrialEmily C L Wong, John K Marshall, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|August 24, 2023
Alternative Endoscopy Reading Paradigms Determine Score Reliability and Effect Size in Ulcerative ColitisWalter Reinisch, Vivek Pradhan, Saira Ahmad, et al.
Inflammatory Bowel Diseases|April 4, 2015
Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?Neeraj Narula, Michael Fine, Jean-Frederic Colombel, et al.
Pageof 36

Showing results (21-30 of 352) with videos related to

Sort By:
Pageof 36
Journal of Crohn'S & Colitis|August 24, 2022
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical ResearchNeeraj Narula, Shahin Merat, David Liu, et al.
Journal of Crohn'S & Colitis|June 11, 2020
Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 PandemicWalter Reinisch, Silvio Danese, Laurent Peyrin-Biroulet, et al.
British Journal of Clinical Pharmacology|November 13, 2020
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease managementAna-Marija Grisic, Alexander Eser, Wilhelm Huisinga, et al.
Gut|March 23, 2021
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare SystemNabeel Khan, Nadim Mahmud, Chinmay Trivedi, et al.
Journal of Crohn'S & Colitis|July 26, 2023
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial DataRyan C Ungaro, Harisha Kadali, Wenwen Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
Clinical Decision Support Tool for Infliximab in Crohn's DiseaseParambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
Human Mutation|August 19, 2006
Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme functionElke Schaeffeler, Michel Eichelbaum, Walter Reinisch, et al.
Inflammatory Bowel Diseases|August 20, 2020
Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI TrialEmily C L Wong, John K Marshall, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|August 24, 2023
Alternative Endoscopy Reading Paradigms Determine Score Reliability and Effect Size in Ulcerative ColitisWalter Reinisch, Vivek Pradhan, Saira Ahmad, et al.
Inflammatory Bowel Diseases|April 4, 2015
Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?Neeraj Narula, Michael Fine, Jean-Frederic Colombel, et al.
Pageof 36